FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000436249> ?p ?o ?g. }

• W2000436249 endingPage "808" @default.
• W2000436249 startingPage "801" @default.
• W2000436249 abstract "Clinical practice guidelines specific to the medical care of frail older adults have yet to be widely disseminated. Because of the complex conditions associated with frailty, guidelines for frail older patients should be based on careful consideration of the characteristics of this population, balanced against the benefits and harms associated with treatment. In response to this need, the Diabetes Care Program of Nova Scotia (DCPNS) collaborated with the Palliative and Therapeutic Harmonization (PATH) program to develop and disseminate guidelines for the treatment of frail older adults with type 2 diabetes. The DCPNS/PATH guidelines are unique in that they recommend the following: 1.Maintain HbA1c at or above 8% rather than below a specific level, in keeping with the conclusion that lower HbA1c levels are associated with increased hypoglycemic events without accruing meaningful benefit for frail older adults with type 2 diabetes. The guideline supports a wide range of acceptable HbA1c targets so that treatment decisions can focus on whether to aim for HbA1c levels between 8% and 9% or within a higher range (ie, >9% and <12%) based on individual circumstances and symptoms. 2.Simplify treatment by administering basal insulin alone and avoiding administration of regular and rapid-acting insulin when feasible. This recommendation takes into account the variations in oral intake that are commonly associated with frailty. 3.Use neutral protamine Hagedorn (NPH) insulin instead of long-acting insulin analogues, such as insulin glargine (Lantus) or insulin detemir (Levemir), as insulin analogues do not appear to provide clinically meaningful benefit but are significantly more costly. 4.With acceptance of more liberalized blood glucose targets, there is no need for routine blood glucose testing when oral hypoglycemic medications or well-established doses of basal insulin (used alone) are not routinely changed as a result of blood glucose testing. Although these recommendations may appear radical, they are based on careful review of research findings." @default.
• W2000436249 created "2016-06-24" @default.
• W2000436249 creator A5003486011 @default.
• W2000436249 creator A5029424046 @default.
• W2000436249 creator A5032770080 @default.
• W2000436249 creator A5034407839 @default.
• W2000436249 creator A5049733443 @default.
• W2000436249 creator A5071906318 @default.
• W2000436249 date "2013-11-01" @default.
• W2000436249 modified "2023-10-01" @default.
• W2000436249 title "Evidence-Informed Guidelines for Treating Frail Older Adults With Type 2 Diabetes: From the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) Program" @default.
• W2000436249 cites W1486009162 @default.
• W2000436249 cites W1526891233 @default.
• W2000436249 cites W1526927233 @default.
• W2000436249 cites W172609984 @default.
• W2000436249 cites W1965927192 @default.
• W2000436249 cites W1967619173 @default.
• W2000436249 cites W1969106530 @default.
• W2000436249 cites W1971955047 @default.
• W2000436249 cites W1979995154 @default.
• W2000436249 cites W1983269691 @default.
• W2000436249 cites W2002078774 @default.
• W2000436249 cites W2002742325 @default.
• W2000436249 cites W2003235934 @default.
• W2000436249 cites W2005848242 @default.
• W2000436249 cites W2019286098 @default.
• W2000436249 cites W2020591896 @default.
• W2000436249 cites W2021341237 @default.
• W2000436249 cites W2022103668 @default.
• W2000436249 cites W2025544664 @default.
• W2000436249 cites W2026743749 @default.
• W2000436249 cites W2028984320 @default.
• W2000436249 cites W2033839954 @default.
• W2000436249 cites W2041135039 @default.
• W2000436249 cites W2041385012 @default.
• W2000436249 cites W2043990618 @default.
• W2000436249 cites W2048798480 @default.
• W2000436249 cites W2059139929 @default.
• W2000436249 cites W2072841278 @default.
• W2000436249 cites W2073338924 @default.
• W2000436249 cites W2077411129 @default.
• W2000436249 cites W2090816211 @default.
• W2000436249 cites W2092170177 @default.
• W2000436249 cites W2100862440 @default.
• W2000436249 cites W2101592301 @default.
• W2000436249 cites W2105092978 @default.
• W2000436249 cites W2107640783 @default.
• W2000436249 cites W2110840270 @default.
• W2000436249 cites W2111735799 @default.
• W2000436249 cites W2114542756 @default.
• W2000436249 cites W2117343153 @default.
• W2000436249 cites W2124994058 @default.
• W2000436249 cites W2126195161 @default.
• W2000436249 cites W2129688566 @default.
• W2000436249 cites W2130039098 @default.
• W2000436249 cites W2135092775 @default.
• W2000436249 cites W2137349443 @default.
• W2000436249 cites W2139562487 @default.
• W2000436249 cites W2144125787 @default.
• W2000436249 cites W2144465381 @default.
• W2000436249 cites W2144773938 @default.
• W2000436249 cites W2145004264 @default.
• W2000436249 cites W2147515317 @default.
• W2000436249 cites W2149971684 @default.
• W2000436249 cites W2158666727 @default.
• W2000436249 cites W2158938545 @default.
• W2000436249 cites W2159593852 @default.
• W2000436249 cites W2162385842 @default.
• W2000436249 cites W2164059021 @default.
• W2000436249 cites W2164186760 @default.
• W2000436249 cites W2167934691 @default.
• W2000436249 cites W2171294019 @default.
• W2000436249 cites W2172193326 @default.
• W2000436249 cites W2337454357 @default.
• W2000436249 cites W4234897853 @default.
• W2000436249 cites W4249253313 @default.
• W2000436249 doi "https://doi.org/10.1016/j.jamda.2013.08.002" @default.
• W2000436249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24074961" @default.
• W2000436249 hasPublicationYear "2013" @default.
• W2000436249 type Work @default.
• W2000436249 sameAs 2000436249 @default.
• W2000436249 citedByCount "72" @default.
• W2000436249 countsByYear W20004362492013 @default.
• W2000436249 countsByYear W20004362492014 @default.
• W2000436249 countsByYear W20004362492015 @default.
• W2000436249 countsByYear W20004362492016 @default.
• W2000436249 countsByYear W20004362492017 @default.
• W2000436249 countsByYear W20004362492018 @default.
• W2000436249 countsByYear W20004362492019 @default.
• W2000436249 countsByYear W20004362492020 @default.
• W2000436249 countsByYear W20004362492021 @default.
• W2000436249 countsByYear W20004362492022 @default.
• W2000436249 countsByYear W20004362492023 @default.
• W2000436249 crossrefType "journal-article" @default.
• W2000436249 hasAuthorship W2000436249A5003486011 @default.
• W2000436249 hasAuthorship W2000436249A5029424046 @default.
• W2000436249 hasAuthorship W2000436249A5032770080 @default.
• W2000436249 hasAuthorship W2000436249A5034407839 @default.

• next